1. Home
  2. ICFI vs MRVI Comparison

ICFI vs MRVI Comparison

Compare ICFI & MRVI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo ICF International Inc.

ICFI

ICF International Inc.

SELL

Current Price

$86.94

Market Cap

1.3B

ML Signal

SELL

Logo Maravai LifeSciences Holdings Inc.

MRVI

Maravai LifeSciences Holdings Inc.

SELL

Current Price

$7.08

Market Cap

1.2B

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
ICFI
MRVI
Founded
1969
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Professional Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.3B
1.2B
IPO Year
2006
2020

Fundamental Metrics

Financial Performance
Metric
ICFI
MRVI
Price
$86.94
$7.08
Analyst Decision
Buy
Buy
Analyst Count
5
9
Target Price
★ $107.25
$7.83
AVG Volume (30 Days)
159.1K
★ 2.2M
Earning Date
11-05-2026
11-05-2026
Dividend Yield
★ 0.64%
N/A
EPS Growth
N/A
★ 14.29
EPS
★ 2.61
N/A
Revenue
★ $1,229,162,000.00
$185,743,000.00
Revenue This Year
$1.68
$14.01
Revenue Next Year
$5.88
$6.20
P/E Ratio
$33.63
★ N/A
Revenue Growth
★ 3.72
N/A
52 Week Low
$58.83
$2.55
52 Week High
$98.03
$9.42

Technical Indicators

Market Signals
Indicator
ICFI
MRVI
Relative Strength Index (RSI) 57.44 45.42
Support Level $86.43 $5.54
Resistance Level $90.96 $7.60
Average True Range (ATR) 2.22 0.42
MACD 0.49 -0.06
Stochastic Oscillator 85.45 7.82

Price Performance

Historical Comparison
ICFI
MRVI

About ICFI ICF International Inc.

ICF International Inc provides professional services and technology-based solutions, including management, technology and policy consulting and implementation services, to government and commercial clients in the U.S. and internationally. Its government clients include U.S. federal agencies, state and local governments and international governments, as well as commercial clients inside and outside the U.S. It supports clients in Energy, Environment, Infrastructure and Disaster Recovery; Health and Social Programs; and Security and Other Civilian and Commercial markets. The company delivers services across the life cycle of a policy, program or project through Advisory Services, Program Implementation, Analytics Services, Digital Services and Engagement Services.

About MRVI Maravai LifeSciences Holdings Inc.

Maravai LifeSciences Holdings Inc is a life sciences company providing products and services to enable the development of drugs, therapeutics, vaccines and diagnostics, and to support research on human disease. Its product portfolio includes complex nucleic acids, custom enzymes and antibody-based solutions for therapeutic, vaccine, diagnostic and biopharmaceutical production applications. The Company operates through two segments: TriLink, which generates maximum revenue from North America and provides nucleic acid products and services including mRNA, oligonucleotides and related technologies; and Cygnus, which provides biologics safety testing products and services including host cell protein ELISA kits, impurity detection assays and related reagents and services.

Share on Social Networks: